SOURCE: HealthSonix, Inc.

April 12, 2007 15:30 ET

President of HealthSonix Interviewed on WallStreetReporter.com

IRVINE, CA -- (MARKET WIRE) -- April 12, 2007 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is pleased to announce that Michael Ivezic, President of HealthSonix, Inc., was interviewed by a senior analyst at WallStreetReporter.com today, Thursday, April 12th, 2007. The interview is featured on their web site, April 12th and 13th. To listen to the interview please visit www.wallstreetreporter.com.

Wall Street Reporter (Est. 1843) helps smart investors connect with exciting companies through our website, magazines, and conferences. We're probably best known for our exclusive interviews with industry leading CEOs and the world's top investment experts.

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pulses are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive and have no known side effects.

More information regarding HealthSonix and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information

  • Contact:
    HealthSonix, Inc.
    1-877-622-2121